USA is making a $ 1.5 billion deal with Modernna for 100 million doses of Corona vaccine
Moderna Biotechnology and White House announced that the United States has entered into an agreement with the company to purchase 100 million doses of its potential for COVID-19 vaccine for $ 1.5 billion.
In the past few weeks, the US has been making deals for hundreds of millions of potential for COVID vaccines from several companies under the rapid registration process program, which aims to produce a vaccine in the country by the end of the year.
The dose of Modernna is about $ 30.5 per person for two dose system.
Except for her deals with Astrazinica, which offered a lower price per dose to pay R & D costs in advance, all trades priced COVID-@DIGITS vaccines between $ 20 and $ 42 for a treatment session of shots.
This month, Modernna said her potential vaccine (M. R. R Anne A-1273), of the few vaccines that have already reached the final stage of testing that will end in September.
The United States will not pay for its deal with Modern in full unless the company meets the timing criteria for delivering the vaccine.
The United States has made agreements with Johnson & Johnson, Strazinica, Viser, Pointek, Sanovi, and Glaxo Smithkin to purchase their potential vaccines.
Under these agreements, the US will receive more than 500 million doses of for COVID vaccines, assuming the companies concerned have the approval of regulatory bodies. Some deals also give us an option to buy additional doses.
Source: otv.com lb lb lb lb
12/8/2020